BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16651719)

  • 1. Effects of antifungal drugs on proliferation signals in Candida albicans.
    Matsuki M; Kanatsu H; Watanabe T; Ogasawara A; Mikami T; Matsumoto T
    Biol Pharm Bull; 2006 May; 29(5):919-22. PubMed ID: 16651719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal mechanism of hinokitiol against Candida albicans.
    Komaki N; Watanabe T; Ogasawara A; Sato N; Mikami T; Matsumoto T
    Biol Pharm Bull; 2008 Apr; 31(4):735-7. PubMed ID: 18379073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of Candida albicans transformation in response to changes of pH.
    Konno N; Ishii M; Nagai A; Watanabe T; Ogasawara A; Mikami T; Matsumoto T
    Biol Pharm Bull; 2006 May; 29(5):923-6. PubMed ID: 16651720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans.
    Sun L; Liao K; Wang D
    PLoS One; 2015; 10(2):e0117695. PubMed ID: 25710475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyphal formation of Candida albicans is inhibited by salivary mucin.
    Ogasawara A; Komaki N; Akai H; Hori K; Watanabe H; Watanabe T; Mikami T; Matsumoto T
    Biol Pharm Bull; 2007 Feb; 30(2):284-6. PubMed ID: 17268066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of yeast-to-hypha transition in Candida albicans by phorbasin H isolated from Phorbas sp.
    Lee SH; Jeon JE; Ahn CH; Chung SC; Shin J; Oh KB
    Appl Microbiol Biotechnol; 2013 Apr; 97(7):3141-8. PubMed ID: 23229567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of propranolol on hyphae formation signal in Candida albicans.
    Ueno Y; Maruyama N; Kanno M; Watanabe T; Ogasawara A; Mikami T; Matsumoto T
    Biol Pharm Bull; 2009 Jan; 32(1):129-31. PubMed ID: 19122294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Farnesol, a morphogenetic autoregulatory substance in the dimorphic fungus Candida albicans, inhibits hyphae growth through suppression of a mitogen-activated protein kinase cascade.
    Sato T; Watanabe T; Mikami T; Matsumoto T
    Biol Pharm Bull; 2004 May; 27(5):751-2. PubMed ID: 15133261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory activity of linalool against the filamentous growth and biofilm formation in Candida albicans.
    Hsu CC; Lai WL; Chuang KC; Lee MH; Tsai YC
    Med Mycol; 2013 Jul; 51(5):473-82. PubMed ID: 23210679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyphal formation of Candida albicans is controlled by electron transfer system.
    Watanabe T; Ogasawara A; Mikami T; Matsumoto T
    Biochem Biophys Res Commun; 2006 Sep; 348(1):206-11. PubMed ID: 16876761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of diclofenac sodium in the dimorphic transition in Candida albicans.
    Ghalehnoo ZR; Rashki A; Najimi M; Dominguez A
    Microb Pathog; 2010; 48(3-4):110-5. PubMed ID: 20026399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boric acid destabilizes the hyphal cytoskeleton and inhibits invasive growth of Candida albicans.
    Pointer BR; Boyer MP; Schmidt M
    Yeast; 2015 Apr; 32(4):389-98. PubMed ID: 25612315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.
    Sigle HC; Thewes S; Niewerth M; Korting HC; Schäfer-Korting M; Hube B
    J Antimicrob Chemother; 2005 May; 55(5):663-73. PubMed ID: 15790671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes.
    MacPherson S; Akache B; Weber S; De Deken X; Raymond M; Turcotte B
    Antimicrob Agents Chemother; 2005 May; 49(5):1745-52. PubMed ID: 15855491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dietary Food Components Capric Acid and Caprylic Acid Inhibit Virulence Factors in Candida albicans Through Multitargeting.
    Jadhav A; Mortale S; Halbandge S; Jangid P; Patil R; Gade W; Kharat K; Karuppayil SM
    J Med Food; 2017 Nov; 20(11):1083-1090. PubMed ID: 28922057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida albicans PHO81 is required for the inhibition of hyphal development by farnesoic acid.
    Chung SC; Kim TI; Ahn CH; Shin J; Oh KB
    FEBS Lett; 2010 Nov; 584(22):4639-45. PubMed ID: 20965180
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Kim H; Hwang JY; Chung B; Cho E; Bae S; Shin J; Oh KB
    Mar Drugs; 2019 Feb; 17(2):. PubMed ID: 30813382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of clotrimazole against Candida albicans depends on carbon sources, growth phase and morphology.
    Kasper L; Miramón P; Jablonowski N; Wisgott S; Wilson D; Brunke S; Hube B
    J Med Microbiol; 2015 Jul; 64(7):714-723. PubMed ID: 25976001
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Çolak A; Ikeh MAC; Nobile CJ; Baykara MZ
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33148826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.